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The DNA damage response (DDR) signal transduc-
tion pathway is responsible for sensing DNA damage
and further relaying this signal into the cell. ATM is an
apical DDR kinase that orchestrates the activation
and the recruitment of downstream DDR factors to
induce cell-cycle arrest and repair. We have previ-
ously shown that NOTCH1 inhibits ATM activation
upon DNA damage, but the underlying mechanism
remains unclear. Here, we show that NOTCH1 does
not impair ATM recruitment to DNA double-strand
breaks (DSBs). Rather, NOTCH1 prevents binding
of FOXO3a and KAT5/Tip60 to ATM through a mech-
anism in which NOTCH1 competes with FOXO3a for
ATM binding. Lack of FOXO3a binding to ATM leads
to the loss of KAT5/Tip60 association with ATM.
Moreover, expression of NOTCH1 or depletion of
ATM impairs the formation of the FOXO3a-KAT5/
Tip60 protein complex. Finally, we show that phar-
macological induction of FOXO3a nuclear localiza-
tion sensitizes NOTCH1-driven cancers to DNA-
damage-induced cell death.
INTRODUCTION
Ataxia-telengiectasia mutated (ATM) is a phosphatidylinositol-3-
like protein kinase discovered over 20 years ago (Savitsky et al.,
1995). Although several reports describe the role of ATM in the
DNA damage response (DDR), the underlying molecular mecha-
nisms of ATM activation still awaits complete elucidation. It has
been shown that upon DNA damage, ATM is recruited to the
double-strand breaks (DSBs) (Andegeko et al., 2001) through
its interaction with NBS1 (Falck et al., 2005; Nakada et al.,
2003). MRE11, RAD50, andNBS1 form a protein complex known
as MRN, which is one of the first to localize to DSBs (Polo and
Jackson, 2011). Upon MRN-mediated ATM recruitment, a lysine
acetyl-transferase 5 (also known as a Tip60, hereinafter referred
to as KAT5), which binds to ATM indirectly (Sun et al.,
2005, 2010), interacts with histone H3 trimethylated at lysine 9
(H3K9m3). This interaction induces acetyl-transferase activity
of KAT5, which acetylates ATM (Sun et al., 2007, 2009). ATM
acetylation has been proposed to be an early step in ATM activa-2068 Cell Reports 16, 2068–2076, August 23, 2016 ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://tion, preceding autophosphorylation and activation (Sun et al.,
2007). In addition, c-Abl-mediated phosphorylation of KAT5
was shown to be necessary for KAT5 activation in response to
DNA damage (Kaidi and Jackson, 2013).
FOXO3a is a mammalian transcription factor that contains a
unique DNA binding forkhead domain and belongs to the fork-
head box-O family of transcription factors (Calnan and Brunet,
2008). FOXO3a is involved in many cellular processes such as
cell-cycle control, apoptosis, and more recently, DDR. FOXO3a
has been proposed to bind to ATM upon DNA damage and to be
necessary for its activation. Lack of FOXO3a impairs both
ATM autophosphorylation and phosphorylation of its substrates,
although the exact mechanism of FOXO3a-mediated ATM acti-
vation remains unclear (Chung et al., 2012; Tsai et al., 2008).
NOTCH1 is a transmembrane receptor which, upon interac-
tion with one of its ligands, is processed by gamma secretase
protease (Andersen et al., 2012). The cleaved intracellular part
of NOTCH1 (N1IC) released in such processes translocates to
the nucleus and initiates the transcription of NOTCH1 target
genes involved in cell proliferation, differentiation, and survival
(Andersen et al., 2012).
We have recently discovered and reported that NOTCH1 is a
direct inhibitor of ATM, independent from its transcriptional activ-
ity (Vermezovic et al., 2015). Here, we demonstrate that NOTCH1
inactivates ATM by preventing FOXO3a binding to the FRAP-
ATM-TRRAP-C-terminal (FATC) domain of ATM. We show that
FOXO3a is necessary for KAT5 binding to ATM and the formation
of an ATM, FOXO3a, and KAT5 protein complex, hereinafter
referred to as theATMactivation complex (AAC). NOTCH1-medi-
ated FOXO3a displacement results in the impairment of KAT5-
ATM interaction and ATM inactivation. Additionally, we provide
evidence that the expression of NOTCH1 or lack of ATM impairs
the formation of the FOXO3a-KAT5 protein complex, suggesting
that the interaction between these two proteins takes place only
in the context of the AAC. Finally, we show that pharmacological
induction of FOXO3a nuclear localization sensitizes NOTCH1-
driven cancers to DNA damage-induced cell death.RESULTS
NOTCH1Binding toATMDoesNot Impair Recruitment to
DSBs
It has been shown that ATM interacts with NBS1 and that this al-
lows its recruitment to DSBs (Nakada et al., 2003; Falck et al.,rs.
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. NOTCH1 Does Not Inhibit ATM Recruitment to DSBs
(A) CoIP of the ATM with NBS1 in cells expressing, or not expressing, NOTCH1. IGG, immunoglobulin G; WCE, whole-cell extract.
(B) Immunoblot analysis of the HEK293T cells transfected with N1IC-GFP or EGFP constructs followed by fluorescence-activated cell sorting (FACS).
(C) Quantification of the signals shown in (B). pATM signal was normalized to ATM for ‘‘ATM activation’’ analysis, and ATM signal was normalized to H3 signal for
‘‘ATM recruitment’’ analysis. In both cases, signal of NO IR samples was subtracted from IR signal (mean ± SEM; n = 3; two-tailed Student’s t test; *p% 0.05; ns,
not significant).2005). Therefore, we tested whether NOTCH1 expression in-
terferes with ATM-NBS1 interaction. We immunoprecipitated
NBS1 in HEK293T cell lysates expressing, or not expressing, a
constitutively active form of NOTCH1 (N1DE-Flag) (Rustighi
et al., 2009). We observed that NBS1 remains in a complex
with ATM both in NOTCH1-expressing and mock-transfected
cells and regardless of ionizing radiation (IR) treatment (Fig-
ure 1A). Next, we studied whether NOTCH1 expression affects
ATM recruitment to chromatin. To that end, we analyzed, by
immunoblotting, the chromatin fraction of lysates from cells ex-
pressing a nuclear form of NOTCH1 fused to GFP (N1IC-GFP)
and treated with IR. Though ATM was inactivated, as indicated
by the decreased ATM autophosphorylation on serine 1981
(pATM), we could not observe any statistical difference in ATM
recruitment to chromatin upon DNA damage in N1IC-GFP-ex-
pressing cells, as compared to control cells (Figures 1B and
1C). Thus, although NOTCH1 inactivates ATM, it does not do
so by inhibiting ATM recruitment to the DSBs.
FOXO3a Binds Directly to the FATC Domain of ATM
FOXO3a has been described as one of the critical protein factors
necessary for ATM activation (Chung et al., 2012; Tsai et al.,
2008), by virtue of its ability to directly interact with ATM (Tsai
et al., 2008). To probe this interaction more in depth, we mapped
the domain of ATM involved in FOXO3a binding. We performed
immunoprecipitation (IP) of Myc-tagged ATM fragments, span-
ning the entire length of the ATM protein (Figure S1A). We
observed a strong interaction between FOXO3a and a C-termi-
nal ATM fragment (amino acids [aa] 1,965–3,056). Notably, this
fragment contains the 33-aa FATC domain (aa 3,023–3,056),
previously proposed as a critical domain in the regulation of
ATM kinase activity (Jiang et al., 2006). Tomapwith an increased
resolution the interaction domain of ATMwith FOXO3a, we incu-
bated a lysate of cells overexpressing Myc-FOXO3a with beadsbound to purified glutathione S-transferase (GST) fused to 12 in-
dividual fragments encompassing the whole ATM. We observed
a specific interaction of FOXO3a with the ATM fragment span-
ning aa 2,842–3,056 but not with that spanning aa 2,682–3,012
(Figure 2A). The same specific interaction could also be
observed when the GST-ATM fragment spanning 2,842–3,056
aa (hereinafter referred to as GST-ATM) was incubated with
endogenous or recombinant purified FOXO3a, indicating that
such interaction is direct (Figures S1B and S1C). To prove the
essential role of the FATC domain of ATM in FOXO3a binding,
we expressed a full-length ATM (wild-type [WT] ATM) or
ATM lacking the FATC domain (1–2992 aa) (ATMDFATC) in
HEK293T cells. IP experiments demonstrated that the FATC
domain of ATM is essential for its interaction with FOXO3a
(Figure S1D).
We decided to further investigate the nature of the endoge-
nous ATM-FOXO3a complex. We immunoprecipitated endoge-
nous FOXO3a in lysates of cells exposed, or not exposed, to
IR. We observed that FOXO3a was in a complex with ATM inde-
pendently of the induction of DNA damage (Figure 2B). Next, to
determine whether the entire pool of ATM protein is in a complex
with FOXO3a, we performed sequential immunodepletions of
either ATMor FOXO3a, followed by reciprocal immunodepletion.
We observed that, despite the complete immunodepletion of
ATM, the levels of FOXO3a are not dramatically affected. Differ-
ently, immunodepletion of FOXO3a led to significant ATM pro-
tein depletion (Figure S1E). This result indicates that all of ATM
is in a complex with FOXO3a, while not all of FOXO3a is associ-
ated with ATM. We conclude that nuclear ATM is quantitatively
bound to FOXO3a directly through its FATC domain.
NOTCH1 Competes with FOXO3a for ATM Binding
We have previously shown that NOTCH1 binds directly to the
FATC domain of ATM and inactivates ATM in response to IRCell Reports 16, 2068–2076, August 23, 2016 2069
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Figure 2. NOTCH1 Competes with FOXO3a for ATM Binding
(A) Immunoblot analysis of the pull-down experiments with GST or GST-ATM fragments (as indicated) incubated with lysate of HEK293T cells transfected with
Myc-FOXO3a construct.
(B) Immunoblot analysis of the coIP of ATM with FOXO3a.
(C) Immunoblot analysis of the pull-down experiment with GST or GST-ATM (2,842–3,056 aa) incubated with the lysate of HEK293T (asterisk indicates correct
band).
(D) Immunoblot analysis of the coIP of ATM with FOXO3a or NOTCH1 in cells overexpressing FOXO3a or expressing NOTCH1.
(E) Immunofluorescence analysis of the pATM staining in HeLa cells expressing, or not expressing, NOTCH1 or overexpressing FOXO3a (scale bars, 10 mm).
(F) Analysis of the images shown in (E). Percentage of pATM-positive cells (more than three foci) (mean ± SEM; n = 3; two-tailed Student’s t test; p% 0.05).
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(Vermezovic et al., 2015). Therefore, we tested whether NOTCH1
competes with FOXO3a in binding to the FATC domain of ATM.
Thus, we incubated GST-ATM bound to beads with lysates from
cells transfected with N1DE-Flag or empty vector. We observed
that FOXO3a binding to FATC domain of ATM was diminished in
the presence of NOTCH1 (Figure 2C). A similar conclusion was
reached by studying the interaction between endogenous ATM
and FOXO3a proteins by proximity ligation assay (PLA) (Figures
S1F and S1G). Moreover, ATM-FOXO3a interaction was rescued
in the presence of a NOTCH1 inhibitor (DAPT) (Figures S1F and
S1G), which, at the same time, abolished interaction between
ATM and NOTCH1 (Figures S1H and S1I). Reduced interaction
between FOXO3a and ATM did not result from NOTCH1-medi-
ated sequestration of FOXO3a, since no interaction between
NOTCH1 and FOXO3a could be observed (Figure S1J). Consis-
tently, in living cells, the overexpression of FOXO3a leads to a
detectably decreased NOTCH1 and ATM interaction (Figures
S1K and S1L).
Next, we compared the strength of the interactions of
NOTCH1 and FOXO3a to ATM. To do that, we transfected either
Myc-FOXO3a or N1DE-Myc and performed an IP of the Myc-
tagged proteins. We observed that NOTCH1 was binding more
efficiently to ATM than FOXO3a (Figure 2D). This was not due
to the differential distribution of expressed tagged proteins
in distinct cellular compartments (Figure S1M). Moreover, IP of
NOTCH1 or FOXO3a from the nuclear fraction confirmed the
results obtained in whole-cell extracts (Figures S1N and S1O).
Next, we asked whether overexpression of FOXO3a could
rescue NOTCH1-driven inhibition of ATM activation upon IR.
We observed an inhibition of ATM activation, as judged by the
inhibition of pATM foci formation, in cells expressing NOTCH1
but not FOXO3a. Furthermore the overexpression of FOXO3
together with NOTCH1 rescues NOTCH1-mediated ATM inacti-
vation (Figures 2E and 2F).
We concluded that NOTCH1 competes with FOXO3a for the
FATC domain of ATM and binds to it with higher strength.
KAT5 Binds to ATM through FOXO3a
The role of FOXO3a in the activation of ATM remains unclear.
Our results indicate that FOXO3a binds directly to the FATC
domain of ATM and that all of ATM is in a complex with it (Fig-
ures 2 and S1). Next, we asked whether FOXO3a can form a
protein complex with KAT5, which has been reported to bind
to the FATC domain of ATM, although indirectly and indepen-
dently of DNA damage (Sun et al., 2010) (Figure S2A). We immu-
noprecipitated FOXO3a from cell lysates, and we detected
KAT5 in a complex with FOXO3a in cells exposed, or not
exposed, to IR (Figure 3A). In order to exclude the possibility
of DNA potentially bridging the two proteins, we performed
the same IP in the presence or absence of benzonase nuclease,
and this did not affect the interaction between KAT5 and
FOXO3a (Figure S2B). To test whether such interaction was
direct, we performed a pull-down experiment with recombinant
purified proteins GST-KAT5 and FOXO3a: we observed that
KAT5 and FOXO3a can, indeed, bind directly to each other
(Figure S2C).
Next, we aimed at mapping the protein domains of KAT5 and
FOXO3a involved in such interaction. We expressed threesequential Myc-tagged fragments of FOXO3a spanning its whole
length (Figure S2D; fragments 1–3) in HEK293T cells, followed by
IP with anti-Myc antibodies. We observed a specific binding
of KAT5 to the C-terminal part of FOXO3a (500–673 aa) (Fig-
ure S2E). To define more precisely the domain in the C-terminal
region of FOXO3a involved in KAT5 binding, we generated two
different C-terminal fragments of FOXO3a (Figure S2D; frag-
ments 4–5). IP of FOXO3a (fragments 3–5) showed that KAT5
binds to FOXO3a in the C-terminal region, between 620 and
650 aa (Figure S2F).
Next, by using four different constructs spanning the entire
length of KAT5 (Figure S2G; fragments 1–4), we aimed at map-
ping the interaction domains between KAT5 and FOXO3a and
between KAT5 and ATM. We performed IPs in cells expressing
Flag-tagged fragments of KAT5 (1–4). We observed that both
FOXO3a and ATM were binding specifically to the C-terminal
part of KAT5 (285–513 aa) (Figures S2H and S2I). In addition,
we expressed in cells the very C-terminal part of KAT5 (450–
513 aa), and we were able to observe both ATM as well as
FOXO3a binding to it (Figure S2J).
Given that KAT5 was reported to bind to ATM indirectly,
we tested whether FOXO3a was necessary for the binding
of KAT5 to ATM. We transfected cells with small interfering
RNA (siRNA) against FOXO3a (siFOXO3a) or siRNA targeting
LUCIFERASE (control). We observed that, as previously re-
ported (Tsai et al., 2008), cells knocked down for FOXO3a dis-
played an impaired activation of ATM, as shown by reduced
pATM signal (Figure S2K). Next, to assess the interaction be-
tween ATM and KAT5, we immunoprecipitated KAT5. Surpris-
ingly, in the absence of FOXO3a also, the interaction between
KAT5 and ATM was impaired as compared to mock-transfected
cells (Figures 3B and S2L).
Unexpectedly, we observed that reduction of ATM-KAT5
interaction in the cells treated with siRNA against FOXO3a was
partial. Therefore, we asked whether other FOXO family mem-
bers, such as FOXO1 and FOXO4, could contribute to the bind-
ing of ATMandKAT5 in the absence of FOXO3a considering high
conservation of C-terminal region (Figure S2M). Therefore, we
immunoprecipitated FOXO1 and FOXO4, and we observed
that ATM was able to form a protein complex with both of
them (Figures S2N and S2O). Moreover, the IP of KAT5 showed
that FOXO1 and FOXO4 can bind to KAT5 (Figure S2P). Finally,
we also observed that knockdown of FOXO3a results in
increased levels of endogenous FOXO4 (Figure S2Q). To over-
come a problem of potential redundancy between FOXO3a,
FOXO1, and FOXO4, we performed an in vitro binding assay.
We incubated GST-ATM with recombinant KAT5 and recombi-
nant FOXO3a. As previously shown (Sun et al., 2010), we could
not detect any direct interaction between GST-ATM and re-
combinant KAT5, but in the presence of recombinant FOXO3a,
the binding between ATM and KAT5 became evident, demon-
strating that FOXO3a can mediate the interaction between
ATM and KAT5 (Figure 3C).
Next, we checkedwhether the formation of the AAC is affected
by the presence of DNA damage and whether its formation
changes with the cell-cycle progression. Therefore, we per-
formed PLA between the three components of the AAC in cells
exposed, or not exposed, to IR. We could not observe anyCell Reports 16, 2068–2076, August 23, 2016 2071
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Figure 3. FOXO3a Bridges KAT5 Binding to ATM
(A) Immunoblot analysis of the coIP of KAT5 with FOXO3a.
(B) Immunoblot analysis of the coIP of ATM and FOXO3a with KAT5 in cells treated, or not treated, with siRNA against FOXO3a.
(C) Immunoblot analysis of the pull-down experiment with GST-ATM (2,842–3,056 aa) incubated as indicated with the recombinant human KAT5 and recombinant
human FOXO3a proteins (asterisk indicates correct band).
(D) Immunoblot analysis of the coIP of ATM and FOXO3a with Myc-KAT5 fragment (450–513 aa) in the presence or absence of NOTCH1.
(E) Three schemes showing the potential interactions among AAC components: (1) AAC complex; (2) AAC complex in the presence of NOTCH1; (3) two pos-
sibilities of FOXO3a-KAT5 interaction in the absence of ATM.
(F) Immunoblot analysis of the coIP of FOXO3a and ATM with KAT5.changes in the interaction between AAC components in the
presence or absence of DNA damage (Figures S2R–S2W).
Next, to check whether the formation of the AAC is differentially
modulated during the cell cycle, we performed PLA in HeLa
Fucci cells (Sakaue-Sawano et al., 2008).We observed amodest
but reproducible increase in the interactions of all AAC compo-
nents in the S/G2 phase compared to the G1 phase of the cell
cycle (Figures S2X–S2AC). Similar to the observed changes in
the interactions between AAC components, we observed an in-
crease of ATM autophosphorylation in cells in the S/G2 phase of
the cell cycle (Figures S2AD and S2AE). Results consistent with
ours were reported by Pandita et al. (2000), who observed
increased ATM activation upon IR in S-phase cells as compared
to G1 and G2.
Our results demonstrate that NOTCH1 perturbs the binding
of FOXO3a to ATM. Since KAT5 binds to FOXO3a, we asked
whether NOTCH1 has an impact on KAT5 association with
ATM. We immunoprecipitated Myc-tagged KAT5 in cells ex-2072 Cell Reports 16, 2068–2076, August 23, 2016pressing NOTCH1 or mock-transfected cells. We observed
that NOTCH1 expression perturbed binding of KAT5 to ATM,
as compared to the control (Figure 3D). Surprisingly, we
observed that expression of NOTCH1 impaired the binding
of KAT5 not only to ATM but also to FOXO3a (Figure 3D). As
we have already excluded the possibility that NOTCH1 could
sequester FOXO3a (Figure S1J), we hypothesized that the
interaction between FOXO3a and KAT5 may take place only
in the context of the formation of the AAC (Figure 3E). To
test this hypothesis, we performed an IP of Flag-tagged
KAT5 in either WT or Atm knockout mouse embryonic
stem cells (mESCs). Indeed, in the absence of ATM, we could
not detect any interaction between KAT5 and FOXO3a
(Figure 3F).
We propose that KAT5, FOXO3a, and ATM form the AAC,
which is perturbed by NOTCH1 binding to ATM and that this
interaction between FOXO3a and KAT5 is restricted to the
formation of the AAC.
Induction of FOXO3a Nuclear Localization Sensitizes
TALL Cells to DNA-Damage-Mediated Apoptosis
T cell acute lymphoblasic leukemia (TALL) cancer cells carry mu-
tations in the NOTCH1 gene that result in increased expression
and activity of NOTCH1 (Ferrando, 2009). We have previously
shown that treatment of TALL-1 cells with gamma-secretase in-
hibitor (GSI; a widely used NOTCH1 inhibitor that prevents its
nuclear translocation) leads to increased activation of DDR
signaling and ensuing DDR-induced cell death (Vermezovic
et al., 2015). Consequently, we decided to testwhetherGSI treat-
ment of TALL cells has an impact on the formation of the AAC. To
that end, we used CUTLL1 cells that express high levels of
NOTCH1. GSI treatment of CUTLL1 cells caused a decrease of
the nuclear formof NOTCH1 aswell as of the interaction between
ATM and NOTCH1 (Figures S3A–S3C). Next, we performed PLA
between ATM and FOXO3a as well as FOXO3a and KAT5 in GSI-
treated cells. We observed that inhibition of NOTCH1 resulted in
the increase of the interaction between ATMand FOXO3a aswell
as that between FOXO3a and KAT5 (Figures S3D–S3G).
On the basis of the results showing that NOTCH1 expression in
TALLcells leads to the impairmentof theAACformation,weasked
whether we can rescue NOTCH1-mediated ATM inactivation in
the TALL cells by increasing levels of FOXO3a in the nucleus.
Therefore, we tested whether the induced translocation of
FOXO3a into the nuclei of TALL-1 cells would have an impact on
ATM activation as well as their survival after exposure to IR. We
pretreated TALL-1 cells with metformin (MET), which, by acting
through AMPK, induces FOXO3a nuclear import (Hu et al.,
2014). To confirm the effect of MET, we analyzed the expression
levels of FOXO3a target gene (GADD45a). We observed that
MET treatment resulted in FOXO3a nuclear accumulation in
TALL-1 cells (Figures S3H and S3I). Next, we analyzed the effect
of MET on TALL-1 cells subjected to IR. Pretreatment with MET
resulted in an increase of ATM activation (pATM) upon IR as
compared to mock-treated cells (Figure 4A; Figure S3J). More-
over, we observed an increase of DDR-induced cell death in
MET-treated cells (Figure 4B). As FOXO3a is not a direct target
of MET, we sought to modulate an independent pathway that
has an impact on FOXO3a nuclear localization. For this purpose,
we tested the impact of pharmacological inhibition of p38 on
TALL-1 cells by the use of a p38 kinase inhibitor (SB203580; here-
inafter referred to as SB) previously shown to induce FOXO3a
nuclear localization in treated cells (Clavel et al., 2010). We pre-
treated TALL-1 cells with SB and exposed them to IR. We
observed an increase of FOXO3a nuclear import as judged by
augmented transcription of a FOXO3a target gene (Figure S3K)
and FOXO3a nuclear localization (Figure S3L). Furthermore,
we observed that SB pretreatment increased ATM activation
(pATM), as well as IR-induced cell death, when compared to
mock-treatedcells (Figures 4C,S3M, andS3N) and that cell death
was dependent on ATM activation (Figure S3O).
We conclude that induction of FOXO3a nuclear localization
sensitizes TALL-1 cells to DNA damage-induced cell death.
DISCUSSION
DDR is one of the most important signaling pathways in the cell,
and it is responsible for the maintenance of genome integrity.Here we show that NOTCH1 inhibits DDR by impairing the
formation of the AAC composed from ATM, FOXO3a, and
KAT5. Our results reveal a hitherto-unknown complex modula-
tion of ATM kinase activity between two factors interacting
with ATM.
It has been shown that NBS1-ATM interaction is crucial for
the MRN-mediated ATM recruitment to DSBs (Falck et al.,
2005; Nakada et al., 2003). Although NBS1 interacts with N-ter-
minal part of ATM, it has been reported that point mutations in
the FATC domain of ATM can affect NBS1 binding to ATM and,
subsequently, ATM localization at DSBs (You et al., 2005; Ogi
et al., 2015). We found that NOTCH1 interacts with ATM
through the FATC domain (Vermezovic et al., 2015), but we
did not observe any impairment in NBS1 binding to ATM or in
its recruitment to DSBs. We show that ATM in the presence
of NOTCH1 can localize at the DSB site but that it does not un-
dergo autophosporylation; this is consistent with some recent
published data (Hartlerode et al., 2015; Yamamoto et al.,
2012). Differently, others reported that autophosphorylation is
necessary for ATM retention at DSBs (So et al., 2009), which
underlies our still-incomplete understanding of the full impact
of ATM autophosphorylation on its activation and recruitment
to DSBs.
FOXO3a has been shown to interact with ATM upon DNA
damage (Tsai et al., 2008). We demonstrate that FOXO3a inter-
acts with ATM independently of the presence of DNA damage.
It has been shown that FOXO3a binds to ATM in a domain span-
ning 1,764–2,841 aa. Although we did observe FOXO3a binding
to this domain, we detected a binding of higher affinity with the
2,842–3,056 aa GST-ATM fragment, which has not been tested
in the previously published study (Tsai et al., 2008).
The exact function of FOXO3a in ATM activation was unclear
thus far. Here, we propose that FOXO3a participates in the pro-
cess of ATM activation by bridging KAT5 to ATM. Previous
studies have shown that KAT5-ATM interaction is mediated by
the FATC domain of ATM and that such binding is indirect, sug-
gesting the existence of one ormore bridging proteins (Sun et al.,
2005, 2010). Consistent with this observation, we show that
FOXO3a, like KAT5, binds specifically to the FATC domain of
ATM, but unlike with KAT5, the observed binding is direct. Unex-
pectedly, we discovered that FOXO3a interacts directly with
KAT5, and, in the absence of FOXO3a, KAT5 loses its ability to
bind to ATM. It is noteworthy that we observed that the FOXO3a
paralogues FOXO1 and FOXO4 could play a similar role in the
absence of FOXO3a. Consistent with this, it has been shown
before that another FOX family member, FOXP3, can interact
with KAT5 (Li et al., 2007).
The interaction between FOXO3a and KAT5 seems to be
restricted to the formation of the AAC, since, both in the absence
of ATM and upon expression of NOTCH1, an interaction be-
tween FOXO3a and KAT5 cannot be detected. Based on that,
we would like to propose a model in which ATM activation is
dependent on the formation of the AAC, which consists of
KAT5, FOXO3a, and ATM proteins. Formation of this three-pro-
tein complex allows proper ATM activation upon DNA damage
(Figure 4E).
We have already shown that IR can be combined with GSI
to sensitize TALL cells to IR-mediated cell death (VermezovicCell Reports 16, 2068–2076, August 23, 2016 2073
Figure 4. Induction of FOXO3a Nuclear Localization Sensitizes TALL Cells to DNA-Damage-Induced Cell Death
(A) Immunoblot analysis of the ATM activation (pATM) in TALL-1 cells pretreated with MET followed by IR.
(B) Immunoblot analysis of the DNA-damage-induced cell death (cleaved caspase-3) in TALL-1 cells pretreated with MET, followed by IR.
(C) Immunoblot analysis of the DNA-damage-induced cell death (cleaved caspase-3) in TALL-1 cells pretreated with SB, followed by IR.
(D) Model of the NOTCH1-mediated inactivation of ATM upon DNA damage. (1) ATM is recruited to DSB by its interaction with the MRN complex. Upon
recruitment of ATM to DSB, KAT5, by interacting with ATM through FOXO3a, binds to H3K9m3 generated by SUV39h1 methyl-transferase, becomes activated,
and acetylates ATM. This leads to ATM activation by autophosphorylation. (2) In the presence of NOTCH1, although ATM is still recruited to DSBs, NOTCH1-
mediated disruption of the KAT5-FOXO3a-ATM complex results in the lack of KAT5-mediated acetylation of ATM and consequent activation.
NI, not irradiated.et al., 2015). Here, we demonstrate the opportunity to use MET
and SB to induce FOXO3a nuclear localization and sensitize
TALL cells to genotoxic treatments. Our results are consistent
with the previous observation that MET stimulates ATM activa-
tion in a FOXO3a-dependent manner (Vazquez-Martin et al.,
2011; Hu et al., 2014).EXPERIMENTAL PROCEDURES
Cell Culture and Treatments
HEK293T cells (Interlab Cell Line Collection) were grown in DMEM supple-
mented with 10% fetal bovine serum (FBS), penicillin/streptomycin, and
L-glutamine. HeLa Fucci cells (RIKEN BioResource Center cell bank) (Sa-
kaue-Sawano et al., 2008) were grown in DMEM supplemented with 10%
FBS, penicillin/streptomycin, and L-glutamine. HeLa cells (ATCC) were
grown in DMEM with GlutaMAX supplemented with 10% FBS, penicillin/
streptomycin, and nonessential aa. TALL-1 cells (DSMZ) were grown in
RPMI 1640 supplemented with 15% FBS, penicillin/streptomycin, and2074 Cell Reports 16, 2068–2076, August 23, 2016L-glutamine. CUTLL1 cells (a kind gift from A. Ferrando) (Palomero et al.,
2006) were grown in RPMI 1640 and supplemented with 10% FBS, peni-
cillin/streptomycin, and L-glutamine. WT mESCs and ATM KO cells (Xu
and Baltimore, 1996) were grown in DMEM with Glutamax (supplemented
with 15% FBS, penicillin/streptomycin, nonessential aa, sodium pyruvate,
leukemia inhibitory factor, and b-mercaptoethanol). HeLa cells were trans-
fected with the use of lipofectamine (Invitrogen), according to the manufac-
turer’s protocol. HEK293T cells were transfected with the use of calcium
phosphate. The GSI DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phe-
nylglycine t-butyl ester) (Sigma) was used at a 10-mM concentration for
16 hr. CUTLL1 cells were treated with 1 mM Compound E (Calbiochem)
for 24 hr before fixation. KU60019 (SelleckChem) was used at the concen-
tration of 10 mM for 16 hr before IR. SB203580 (Jena Bioscience) was used
at the concentration of 10 mM for 24 hr before the IR. MET (Tocris) was used
at the concentration of 500 mM 24 hr before IR. Cells were irradiated with an
X-ray machine (Faxitron): 2 Gy, 1 hr, for immunofluorescence experiments;
5 Gy, 1 hr, for immunoblot analysis of DDR activation; and 10 Gy for DDR-
induced cell-death analysis. For the knockdown experiments, 20 nM siRNA
(GE Dharmacon) against human FOXO3a was transfected with the use of
RNAiMAX lipofectamine (Invitrogen) 48 hr before the experiment.
For the purpose of cell sorting, HEK293T cells were transfected with N1IC-
GFP or EGFP construct and FACS sorted 1 day after for GFP. Next, cells were
plated and, 8 hr later, subjected to IR (10G for recruitment experiments).
Statistical Analysis
All data are represented as means ± SEM. Statistical analysis was performed
with the use of a two-tailed Student’s t test. An asterisk indicates p < 0.05.
For more details, please see the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.07.038.
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